Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy

Biomaterials

Volumn 32, Issue 34, 2011, Pages 8999-9010

  Hua, Mu Yi ^a   Yang, Hung Wei ^a   Liu, Hao Li ^a   Tsai, Rung Ywan ^b   Pang, See Tong ^c   Chuang, Kun Lung ^c   Chang, Yu Sun ^a   Hwang, Tsong Long ^a   Chang, Ying Hsu ^c   Chuang, Heng Chang ^c   Chuang, Cheng Keng ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Bladder cancer; Magnetic resonance image; Magnetic targeting therapy; P glycoprotein pump; Superhigh magnetization nanocarriers

Indexed keywords

BLADDER CANCERS; MAGNETIC RESONANCE IMAGE; MAGNETIC TARGETING; NANOCARRIERS; P-GLYCOPROTEIN;

BUTYRIC ACID; CARRIER CONCENTRATION; DISEASES; DRUG DELIVERY; DRUG DOSAGE; FATTY ACIDS; GLYCOPROTEINS; MAGNETIZATION; PUMPS; SUPERPARAMAGNETISM; TISSUE;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; DOXORUBICIN; FERUCARBOTRAN; GLYCOPROTEIN P; NANOCARRIER; SUPERHIGH MAGNETIZATION NANOCARRIER; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TARGETING; MAGNETIC TARGETING THERAPY; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THERMOSTABILITY;

ANILINE COMPOUNDS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CONTRAST MEDIA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FERUMOXYTOL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETS; MICE; NANOSTRUCTURES; URINARY BLADDER NEOPLASMS;

EID: 80053127356     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.014     Document Type: Article

References (50)

1. Shelley M.D., Mason M.D., Kynaston H. Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 2010, 36:195-205.
2. Chung J., Kwak C., Jin R.J., Lee C.H., Lee K.H., Lee S.E. Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro. Cancer Lett 2004, 203:155-161.
3. Alakhov V., Klinski E., Li S., Pietrzynski G., Venne A., Batrakova E., et al. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf B Biointerfaces 1999, 16:113-134.
4. Zhang H.Z., Gao F.P., Liu L.R., Li X.M., Zhou Z.M., Yang X.D., et al. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy. Colloids Surf B Biointerfaces 2009, 71:19-26.
5. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 2008, 60:1650-1662.
6. Chang L.C., Wu S.C., Tsai J.W., Yu T.J., Tsai T.R. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery. Int J Pharm 2009, 376:195-203.
7. Kwon G.S., Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 1996, 21:107-116.
8. Kim J.O., Kabanov A.V., Bronich T.K. Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J Control Release 2009, 138:197-204.
9. Lavasanifar A., Samuel J., Kwon G.S. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002, 54:169-190.
10. Soga O., van Nostrum C.F., Fens M., Rijcken C.J.F., Schiffelers R.M., Storm G., et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 2005, 103:341-353.
11. Wang Y.S., Liu L.R., Jiang Q., Zhang Q.Q. Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin. Eur Polym J 2007, 43:43-51.
12. Azarmi S., Roa W.H., Löbenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev 2008, 60:863-875.
13. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
14. Rahimi M., Wadajkar A., Subramanian K., Yousef M., Cui W., Hsieh J.T., et al. In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine 2010, 6:672-680.
15. Ma Y.H., Wu S.Y., Wu T., Chang Y.J., Hua M.Y., Chen J.P. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials 2009, 30:3343-3351.
16. Gamarra L.F., Brito G.E.S., Pontuschka W.M., Amaro E., Parma A.H.C., Goya G.F. Biocompatible superparamagnetic iron oxide nanoparticles used for contrast agents: a structural and magnetic study. J Magn Magn Mater 2005, 289:439-441.
17. 4 nanoparticles and their biomedical applications. Biomaterials 2005, 26:729-738.
18. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
19. McCarthy J.R., Jaffer F.A., Weissleder R. A macrophage-targeted theranostic nanoparticle for biomedical applications. Small 2006, 2:983-987.
20. Asmatulu R., Zalich M.A., Claus R.O., Riffle J.S. Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J Magn Magn Mater 2005, 292:108-119.
21. Ma Y.-H., Hsu Y.-W., Chang Y.-J., Hua M.-Y., Chen J.-P., Wu T. Intra-arterial application of magnetic nanoparticles for targeted thrombolytic therapy: a rat embolic model. J Magn Magn Mater 2007, 311:34-36.
22. Hua M.Y., Yang H.W., Chuang C.K., Tsai R.Y., Chen W.J., Chuang K.L., et al. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials 2010, 31:7355-7363.
23. Mahmoudi M., Simchi A., Imani M., Häfeli U.O. Superparamagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J Phys Chem C 2009, 113:8124-8131.
24. Hong J., Xu D., Gong P., Yu J., Ma H., Yao S. Covalent-bonded immobilization of enzyme on hydrophilic polymer covering magnetic nanogels. Microporous Mesoporous Mater 2008, 109:470-477.
25. Lee G., Kim J., Lee J.-h. Development of magnetically separable polyaniline nanofibers for enzyme immobilization and recovery. Enzym Microb Technol 2008, 42:466-472.
26. Lee D.-G., Ponvel K.M., Kim M., Hwang S., Ahn I.-S., Lee C.-H. Immobilization of lipase on hydrophobic nano-sized magnetite particles. J Mol Catal B Enzym 2009, 57:62-66.
27. Liberti P.A., Rao C.G., Terstappen L.W.M.M. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 2001, 225:301-307.
28. Vinogradov S.V., Bronich T.K., Kabanov A.V. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 2002, 54:135-147.
29. Nam H.Y., Kwon S.M., Chung H., Lee S.Y., Kwon S.H., Jeon H., et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release 2009, 135:259-267.
30. Brown M.A., Semelka R.C. Relaxation. MRI: basic principles and applications 2003, Wiley-Liss, New York, pp. 17-27.
31. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni A. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56:185-229.
32. Hayes M.C., Birch B.R., Cooper A.J., Primrose J.N. Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1). BJU Int 2001, 87:245-250.
33. Guo S., Li D., Zhang L., Li J., Wang E. Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery. Biomaterials 2009, 30:1881-1889.
34. Kayal S., Ramanujan R.V. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C 2010, 30:484-490.
35. Yang X., Chen L., Han B., Yang X., Duan H. Preparation of magnetite and tumor dual-targeting hollow polymer microspheres with pH-sensitivity for anticancer drug-carriers. Polymer 2010, 51:2533-2539.
36. Pankhurst Q.A., Connolly J., Jones S.K. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003, 36:R167-R181.
37. Lewin J.M., Lwaleed B.A., Cooper A.J., Birch B.R. The direct effect of nuclear pores on nuclear chemotherapeutic concentration in multidrug resistant bladder cancer: the nuclear sparing phenomenon. J Urol 2007, 177:1526-1530.
38. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55:329-347.
39. Breunig M., Bauer S., Goepferich A. Polymers and nanoparticles: intelligent tools for intracellular targeting?. Eur J Pharm Biopharm 2008, 68:112-128.
40. Hua M.Y., Liu H.L., Yang H.W., Chen P.Y., Tsai R.Y., Huang C.Y., et al. The effectiveness of a magnetic-nanoparticle-based delivery system for BCNU in the treatment of Gliomas. Biomaterials 2011, 32:516-527.
41. 2 nanoparticles with surfactants. Colloids Surf A Physicochem Eng Asp 2009, 348:270-275.
42. 2 agglomerates in electrostatically stabilized aqueous dispersions. Powder Technol 2005, 160:121-126.
43. Liu C.G., Desai K.G.H., Chen X.G., Park H.J. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles. J Agric Food Chem 2005, 53:437-441.
44. Dini L., Abbro L. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 2005, 36:195-217.
45. Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Wu J.S., et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci USA 2010, 107:15205-15210.
46. Pereira M.C., Pereira M.L., Sousa J.P. Histological effects of iron accumulation on mice liver and spleen after administration of a metallic solution. Biomaterials 1999, 20:2193-2198.
47. Zhao Y., Li H., Gao Z., Xu H. Effects of dietary baicalin supplementation on iron overload-induced mouse liver oxidative injury. Eur J Pharmacol 2005, 509:195-200.
48. Cha S.K., Wu T., Huang C.L. Protein kinase C inhibits caveolae-mediated endocytosis of TRPV5. Am J Physiol Ren Physiol 2008, 294:F1212-F1221.
49. Toyoshi F., Masami H., Machiko I., Ohno-Iwashita Y. Crosslinked plasmalemmal cholesterol is sequestered to caveolae: analysis with a new cytochemical probe. J Histochem Cytochem 1997, 45:1197-1205.
50. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004, 377:159-169.